RenovoRx, Inc.
A clinical-stage company developing targeted oncology therapies for solid tumors.
RNXT | US
Overview
Corporate Details
- ISIN(s):
- US75989R1077
- LEI:
- Country:
- United States of America
- Address:
- 2570 W. EL CAMINO REAL, STE. 320,, 94040 MOUNTAIN VIEW
- Website:
- https://renovorx.com/
Description
RenovoRx, Inc. is a clinical-stage life sciences company developing targeted oncology therapies for solid tumors. The company's core technology is its proprietary Trans-Arterial Micro-Perfusion (TAMP) therapy platform, which is designed for the localized delivery of therapeutic agents directly to tumors. This approach aims to enhance treatment efficacy while minimizing the systemic toxicities associated with conventional intravenous chemotherapy. The TAMP platform is enabled by the RenovoCath®, an FDA-cleared dual-balloon infusion catheter that isolates blood flow for targeted drug delivery. RenovoRx is advancing its lead drug-device combination product candidate in the Phase III TIGeR-PaC clinical trial for the treatment of locally advanced pancreatic cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all RenovoRx, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for RenovoRx, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for RenovoRx, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
